Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | TLR7 | Q9NYK1 | 2/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7739561 | 0.90 | KDM4E (0.42) | ALDH1A1KDM4ESMN1; SMN2LMNAHTT | |
| SCHEMBL7734611 | 0.88 | POLB (0.40) | ALDH1A1KDM4ESMN1; SMN2LMNAHTT | |
| SCHEMBL7734767 | 0.87 | KDM4E (0.40) | ALDH1A1KDM4ESMN1; SMN2LMNAHTT | |
| SCHEMBL7740710 | 0.86 | ALDH1A1 (0.45) | ALDH1A1KDM4ESMN1; SMN2LMNAHTT | |
| SCHEMBL7739420 | 0.82 | MAPT (0.50) | ALDH1A1KDM4ESMN1; SMN2LMNAGAA | |
| SCHEMBL7739350 | 0.78 | KDM4E (0.43) | ALDH1A1KDM4ESMN1; SMN2LMNAHTT | |
| SCHEMBL7740723 | 0.77 | MEN1 (0.36) | ALDH1A1KDM4ESMN1; SMN2LMNAHTT | |
| SCHEMBL7740373 | 0.73 | KMT2A (0.43) | ALDH1A1KDM4ESMN1; SMN2LMNAHTT | |
| SCHEMBL7740065 | 0.72 | MAPT (0.50) | ALDH1A1KDM4ESMN1; SMN2HTTKMT2A | |
| SCHEMBL7734550 | 0.72 | GRIN1 (0.50) | KDM4ERXFP1KMT2AMEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6420410-B1 | ADMINISTERING N,N'-SUBSTITUTED BENZIMIDAZOL-2-ONES TO INDUCE APOPTOSIS IN NEOPLASTIC CELLS BUT NOT NORMAL CELLS; ANTICANCER, ANTITUMOR AGENT | CELL PATHWAYS, INC. | 2002-07-16 | — | — | US | disclosed |